Literature DB >> 1664864

Methadone dose and urine morphine.

J F Maddux1, M Esquivel, K N Vogtsberger, D P Desmond.   

Abstract

When methadone maintenance was introduced in 1965, daily doses of approximately 100 mg were advocated and used; later, doses under 50 mg became common; recently, doses between 50 and 100 mg have been recommended. In a historical study and a cross-section study in one program the authors found no relationship between methadone dose and urine morphine. Patients on methadone doses under 50 mg had nearly the same percentage of urine tests positive for morphine as did those on doses of 50 mg and more. Gender, ethnic background, and age were also unrelated to urine morphine. Time on methadone was inversely related to urine morphine. Patients maintained on methadone for 3 years or longer showed a marked decrease in urine tests positive for morphine. Increased urine morphine during one decade was associated with program and community changes that could have prompted increased heroin use. These findings suggest that variables other than methadone dose affect heroin use.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1664864     DOI: 10.1016/0740-5472(91)90039-d

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  5 in total

Review 1.  Methadone maintenance treatment in opiate dependence: a review.

Authors:  M Farrell; J Ward; R Mattick; W Hall; G V Stimson; D des Jarlais; M Gossop; J Strang
Journal:  BMJ       Date:  1994-10-15

2.  Factors associated with illicit opioid use in methadone maintenance treatment clients in 5 Provinces, China.

Authors:  Weixiu Li; Ziyun Wang; Zhimin Liu
Journal:  Environ Health Prev Med       Date:  2016-10-03       Impact factor: 3.674

3.  Pathological gamblers in methadone treatment: A comparison between men and women.

Authors:  B Spunt; H Lesieur; H J Liberty; D Hunt
Journal:  J Gambl Stud       Date:  1996-12

4.  Contribution of the activities of CYP3A, CYP2D6, CYP1A2 and other potential covariates to the disposition of methadone in patients undergoing methadone maintenance treatment.

Authors:  Mohammad-Reza Shiran; Martin S Lennard; Mohammad-Zafar Iqbal; Oldwale Lagundoye; Nicholas Seivewright; Geoffrey T Tucker; Amin Rostami-Hodjegan
Journal:  Br J Clin Pharmacol       Date:  2009-01       Impact factor: 4.335

5.  A randomized investigation of methadone doses at or over 100 mg/day, combined with contingency management.

Authors:  Ashley P Kennedy; Karran A Phillips; David H Epstein; David A Reamer; John Schmittner; Kenzie L Preston
Journal:  Drug Alcohol Depend       Date:  2012-11-26       Impact factor: 4.492

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.